TY - JOUR
T1 - Physiological Microenvironment Dependent Self-Cross-Linking of Multifunctional Nanohybrid for Prolonged Antibacterial Therapy via Synergistic Chemodynamic-Photothermal-Biological Processes
AU - Liu, Yi
AU - Chen, Wei
AU - Mu, Wenyun
AU - Zhou, Qian
AU - Liu, Jie
AU - Li, Baixue
AU - Liu, Tao
AU - Yu, Tingting
AU - Hu, Nan
AU - Chen, Xin
N1 - Publisher Copyright:
© 2024 American Chemical Society
PY - 2024/6/12
Y1 - 2024/6/12
N2 - Herein, a multifunctional nanohybrid (PL@HPFTM nanoparticles) was fabricated to perform the integration of chemodynamic therapy, photothermal therapy, and biological therapy over the long term at a designed location for continuous antibacterial applications. The PL@HPFTM nanoparticles consisted of a polydopamine/hemoglobin/Fe2+ nanocomplex with comodification of tetrazole/alkene groups on the surface as well as coloading of antimicrobial peptides and luminol in the core. During therapy, the PL@HPFTM nanoparticles would selectively cross-link to surrounding bacteria via tetrazole/alkene cycloaddition under chemiluminescence produced by the reaction between luminol and overexpressed H2O2 at the infected area. The resulting PL@HPFTM network not only significantly damaged bacteria by Fe2+-catalyzed ROS production, effective photothermal conversion, and sustained release of antimicrobial peptides but dramatically enhanced the retention time of these therapeutic agents for prolonged antibacterial therapy. Both in vitro and in vivo results have shown that our PL@HPFTM nanoparticles have much higher bactericidal efficiency and remarkably longer periods of validity than free antibacterial nanoparticles.
AB - Herein, a multifunctional nanohybrid (PL@HPFTM nanoparticles) was fabricated to perform the integration of chemodynamic therapy, photothermal therapy, and biological therapy over the long term at a designed location for continuous antibacterial applications. The PL@HPFTM nanoparticles consisted of a polydopamine/hemoglobin/Fe2+ nanocomplex with comodification of tetrazole/alkene groups on the surface as well as coloading of antimicrobial peptides and luminol in the core. During therapy, the PL@HPFTM nanoparticles would selectively cross-link to surrounding bacteria via tetrazole/alkene cycloaddition under chemiluminescence produced by the reaction between luminol and overexpressed H2O2 at the infected area. The resulting PL@HPFTM network not only significantly damaged bacteria by Fe2+-catalyzed ROS production, effective photothermal conversion, and sustained release of antimicrobial peptides but dramatically enhanced the retention time of these therapeutic agents for prolonged antibacterial therapy. Both in vitro and in vivo results have shown that our PL@HPFTM nanoparticles have much higher bactericidal efficiency and remarkably longer periods of validity than free antibacterial nanoparticles.
KW - Continuous and effective antibacterial therapy
KW - Integration of chemodynamic−photothermal−biological bacteriostatic activities
KW - Multifunctional nanohybrid
KW - Physiological microenvironment dependent self-cross-linking
KW - Significant enhancement of validity period
UR - https://www.scopus.com/pages/publications/85195315868
U2 - 10.1021/acs.nanolett.4c00671
DO - 10.1021/acs.nanolett.4c00671
M3 - 文章
C2 - 38829311
AN - SCOPUS:85195315868
SN - 1530-6984
VL - 24
SP - 6906
EP - 6915
JO - Nano Letters
JF - Nano Letters
IS - 23
ER -